Skip to content

Inspection Record

Fenwal International, Inc. — FDA 483 Findings

US FDAInspected 2024-09-18Published 2026-10-30 7 findingsEquipment and facilityQuality unit oversightLaboratory and QC controls

Inspectors Scott T Ballard · Cody D Rickman · Lizaida PerezThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

Buildings used in the of a drug product are not maintained in a good state of repair.

2Equipment and facility

Equipment used in the manufacture, (b)(4) of drug products is not of appropriate design to facilitate operations for its intended use.

3Equipment and facility

Equipment for adequate control over air pressure is not provided when appropriate for the manufacture, (b)(4) of a drug product.

4Quality unit oversight

Records are not maintained so that data therein can be reviewed at least annually to evaluate the quality standards of each drug product to determine the need for changes in specifications or manufacturing or control procedures.

5Equipment and facility

Washing and toilet facilities lack hot and cold water.

6Equipment and facility

Equipment and) (b)(4) |are not maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

7Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that in-process materials conform to appropriate standards of identity, strength, quality and purity.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-30. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Fenwal International, Inc. company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.